CDH2 and central nervous system cancer: Epithelial‐mesenchymal transition is characterized by loss of epithelial markers (eg E‐cadherin) and gain of mesenchymal markers (eg N‐cadherin, β‐catenin, Twist1), and it has been considered to be an important regulator of the invasiveness of glioma cell.29